Los Angeles Capital Management LLC Ironwood Pharmaceuticals Inc Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

A detailed history of Los Angeles Capital Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 12,172 shares of IRWD stock, worth $48,201. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,172

Previous 36,846 66.97%

Holding current value

$48,201

Previous $240,000 79.17%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$3.93 - $7.04 $96,968 - $173,704	-24,674 Reduced 66.97%	12,172 $50,000
Q2 2024 Aug 05, 2024	SELL	$5.58 - $8.61 $270,613 - $417,559	-48,497 Reduced 56.83%	36,846 $240,000
Q1 2024 Apr 05, 2024	BUY	$8.32 - $15.45 $480,945 - $893,102	57,806 Added 209.92%	85,343 $743,000
Q4 2023 Feb 06, 2024	SELL	$8.79 - $11.51 $201,976 - $264,476	-22,978 Reduced 45.49%	27,537 $315,000
Q3 2023 Nov 06, 2023	SELL	$8.25 - $11.35 $1.35 Million - $1.86 Million	-164,146 Reduced 76.47%	50,515 $486,000
Q2 2023 Aug 03, 2023	BUY	$10.1 - $11.6 $223,260 - $256,418	22,105 Added 11.48%	214,661 $2.28 Million
Q1 2023 May 04, 2023	SELL	$10.37 - $12.56 $91,141 - $110,389	-8,789 Reduced 4.37%	192,556 $2.03 Million
Q4 2022 Feb 06, 2023	BUY	$9.9 - $12.43 $475,566 - $597,099	48,037 Added 31.33%	201,345 $2.49 Million
Q3 2022 Nov 02, 2022	BUY	$10.14 - $12.38 $951,486 - $1.16 Million	93,835 Added 157.78%	153,308 $1.59 Million
Q4 2021 Feb 03, 2022	SELL	$10.86 - $13.95 $7,319 - $9,402	-674 Reduced 1.12%	59,473 $693,000
Q3 2021 Nov 08, 2021	BUY	$11.92 - $13.92 $28,131 - $32,851	2,360 Added 4.08%	60,147 $786,000
Q2 2021 Aug 05, 2021	SELL	$10.16 - $13.11 $33,070 - $42,673	-3,255 Reduced 5.33%	57,787 $744,000
Q1 2021 May 05, 2021	SELL	$9.04 - $11.86 $734,951 - $964,218	-81,300 Reduced 57.12%	61,042 $682,000
Q4 2020 Feb 04, 2021	SELL	$9.05 - $12.2 $8,126 - $10,955	-898 Reduced 0.63%	142,342 $1.62 Million
Q3 2020 Nov 02, 2020	SELL	$8.99 - $10.74 $126,021 - $150,553	-14,018 Reduced 8.91%	143,240 $1.29 Million
Q2 2020 Aug 05, 2020	BUY	$9.14 - $11.97 $50,105 - $65,619	5,482 Added 3.61%	157,258 $1.62 Million
Q1 2020 May 04, 2020	BUY	$8.58 - $14.01 $249,635 - $407,620	29,095 Added 23.72%	151,776 $1.53 Million
Q4 2019 Feb 07, 2020	BUY	$8.22 - $14.0 $374,700 - $638,176	45,584 Added 59.13%	122,681 $1.63 Million
Q2 2019 Jul 29, 2019	BUY	$9.8 - $12.89 $238,581 - $313,807	24,345 Added 46.15%	77,097 $843,000
Q1 2019 Apr 25, 2019	BUY	$8.27 - $12.73 $436,259 - $671,532	52,752 New	52,752 $714,000
Q3 2018 Nov 05, 2018	SELL	$14.31 - $17.65 $233,467 - $287,959	-16,315 Closed	0 $0
Q2 2018 Jul 31, 2018	SELL	$11.83 - $16.2 $305,273 - $418,041	-25,805 Reduced 61.27%	16,315 $312,000
Q1 2018 Apr 27, 2018	BUY	$11.13 - $13.63 $468,795 - $574,095	42,120 New	42,120 $650,000

Others Institutions Holding IRWD

# of Institutions

236

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $607M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Ironwood Pharmaceuticals Inc Transaction History